Protalix BioTherapeutics (PLX) Other financing activities (2010 - 2016)

Protalix BioTherapeutics has reported Other financing activities for 6 years, with the latest figure at $14000.0 in Q4 2016.

• On a quarterly basis, Other financing activities changed N/A year-over-year to $14000.0 in Q4 2016; TTM through Dec 2022 was $14000.0, a N/A change from a year earlier, with the FY2023 full-year figure at $712000.0, up 35500.0% from the prior year.
• Other financing activities was $14000.0 for Q4 2016 at Protalix BioTherapeutics, down from $31000.0 in the prior quarter.
• The five-year high for Other financing activities was $1.0 million in Q2 2012, with the low at $2000.0 in Q2 2013.
• Average Other financing activities over 4 years is $154111.1, with a median of $31000.0 recorded in 2014.
• The sharpest annual moves came in 2012 and 2013: Other financing activities jumped 34900.0% in 2012, then sank 99.81% in 2013.
• Over 4 years, Other financing activities stood at $134000.0 in 2012, then sank by 38.81% to $82000.0 in 2013, then plunged by 62.2% to $31000.0 in 2014, then sank by 54.84% to $14000.0 in 2016.
• The last three Other financing activities figures came in at $14000.0 (Q4 2016), $31000.0 (Q1 2014), and $82000.0 (Q4 2013), per Business Quant data.